Health Condition 1: M545- Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: WHO GUIDELINES 2023Participants will be included in the study if they meet the following conditions: Adults aged between 20 and 55 years. Diagnosed with chronic non-specific low back pain confirmed through diagnostic triage persisting for more than 12 weeks without identifiable spinal pathology [1,2]. Pain localized between the lower costal margin and gluteal folds[1].Pain intensity between 3 and 7 on a validated pain scale such as the Numerical Pain Rating Scale (NPRS) .Functional disability ranging from mild to moderate, as per standard outcome measures used in previous DNS and PNF trials [3,4].Capable of understanding verbal instructions and providing written informed consent to participate in the intervention programe.
Exclusion criteria
Exclusion criteria: Exclusion based on Specific Spinal Pathology (Red Flags): History or clinical suspicion of: Vertebral fracture, Spinal malignancy, Spinal infection, Inflammatory spondyloarthropathy (e.g., axial spondylarthritis), Cauda equina syndrome, (Red flag criteria from diagnostic triage model: Night pain, unexplained fever, chills, significant trauma, weight loss, immunosuppression, or prolonged corticosteroid use. Exclusion based on Radicular Syndrome: Participants demonstrating any of the following signs will be excluded: Radiating leg pain worse than back pain, Dermatomal sensory loss, Myotomal weakness or foot drop, Reduced knee or ankle reflex, Positive neural tension tests (SLR, CSLR, PKB), Neurogenic claudication or symptoms relieved by spinal flexion through triage. Other Clinical Exclusion Criteria: Previous spinal surgery or known neurological disorders affecting trunk control or balance. Pregnancy or systemic diseases that contraindicate active exercise therapy (e.g., severe osteoporosis, uncontrolled metabolic or cardiovascular disease). Current participation in any other physiotherapy, rehabilitation, or pain management program within the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity Numerical Pain Rating Scale (NPRS)Timepoint: Outcome will be assessed at Baseline and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| OSWESTRY DISABILITY INDEX (ODI) measure Functional disabilityTimepoint: Baseline (pre-intervention) and at 8 weeks post-intervention;TAMPA SCALE 11: Measure KinesiophobiaTimepoint: Baseline (pre-intervention) and at 8 weeks post-intervention. | — |
Countries
India
Contacts
Chettinad Academy of Research and Education, Chettinad School of Physiotherapy